Results 11 to 20 of about 9,670 (235)

Spontaneous remission of angioimmunoblastic T-cell lymphoma in a child with ataxia–telangiectasia: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2023
Background Angioimmunoblastic T-cell lymphoma is an uncommon subtype of peripheral T-cell lymphoma in children with fewer than 20 cases reported in literature.
Dima Abla   +5 more
doaj   +2 more sources

Pleuropneumonia Revealing Angioimmunoblastic T-cell Lymphoma [PDF]

open access: yesCureus
Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of lymphoma that presents with a wide range of symptoms, including multiple lymphadenopathies, systemic symptoms, splenomegaly, hepatomegaly, and skin rashes. Due to its atypical presentation, diagnosis can be delayed, and confirmation relies on lymph node biopsy.
Salhi, Zineb   +7 more
openaire   +3 more sources

Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge [PDF]

open access: yesCase Reports in Dermatology, 2014
Angioimmunoblastic T-cell lymphoma (AITL) accounts for 15-20% of all peripheral T-cell lymphomas. It is a rare subtype of CD4 T-cell peripheral lymphoma that affects aged individuals, causing B symptoms, generalized lymphadenopathy and hepatosplenomegaly.
Jorge Ocampo-Garza   +8 more
doaj   +4 more sources

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research
Background For angioimmunoblastic T cell lymphoma (AITL), a rare cancer, no specific treatments are available and survival outcome is poor. We previously developed a murine model for AITL that mimics closely human disease and allows to evaluate new ...
Adrien Krug   +7 more
doaj   +2 more sources

Complete hematologic response in a patient with multiple pretreated angioimmunoblastic T‐cell lymphoma after belinostat therapy followed by allogeneic stem cell transplantation: A case report [PDF]

open access: yesClinical Case Reports
Key Clinical Message Belinostat therapy followed by hematopoietic stem cell transplantation is a promising salvage strategy for heavily pretreated patients with peripheral T‐cell lymphoma.
Sigrid De Wilde, Carlos Graux
doaj   +2 more sources

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma [PDF]

open access: hybridAm J Hematol
Alyssa Bouska   +43 more
openalex   +2 more sources

Peripheral T-Cell Lymphomas of the T Follicular Helper Type: Clinical, Pathological, and Genetic Attributes

open access: yesHemato, 2022
Follicular helper T-cell (TFH) lymphomas comprise a unique group of T-cell lymphomas that represent neoplastic proliferations of follicular helper T-cells and share genetic, immunophenotypic, morphologic, and clinical features.
Karthik A. Ganapathi   +2 more
doaj   +1 more source

Conjunctival Angioimmunoblastic T-Cell Lymphoma [PDF]

open access: yesOcular Oncology and Pathology, 2014
Angioimmunoblastic T-cell lymphoma (AITL) represents an uncommon variant of T-cell lymphomas and most often presents insidiously with systemic symptoms. This report constitutes the first documented case of conjunctival AITL, masquerading as nodular episcleritis, and describes both the clinical and pathological findings. Furthermore, conjunctival T-cell
Darshak S. Patel   +4 more
openaire   +2 more sources

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma

open access: yesFrontiers in Oncology, 2022
Peripheral T-cell lymphoma (PTCL) is a type of highly heterogeneous non-Hodgkin lymphoma with a poor prognosis and lack of effective targeted therapies. Adoptive T-cell therapy has been successfully used in the treatment of B-cell malignancies.
Yuan Chen   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy